E-DRUG: Industry Control over Information (2)
---------------------------------------------
I can confirm that the data in IMS publications do not always match the
government approved product information. There has been a problem with
discrepancies in Australia which I have been told are now being addressed.
It is important to remember that currently most societies reward
pharmaceutical companies for doing everything that works to increase sales
without modifying the rewards according to the impact on health care.
If permission can be obtained I would like to publish some or all of the
report of Prof Iwan Darmansyah's comments on the MaLAM Website.
Dr Peter Mansfield
Director, MaLAM
MaLAM Headquarters
PO Box 172, Daw Pk SA 5041, Australia
phone/fax +61 8 8374 2245
peter.mansfield@flinders.edu.au
http://www.camtech.net.au/malam
MaLAM encourages pharmaceutical companies to provide more reliable
information to assist appropriate health care.
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.